Manufacturers Life Insurance Company, The Larimar Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 16,161 shares of LRMR stock, worth $108,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,161
Previous 16,615
2.73%
Holding current value
$108,117
Previous $120,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LRMR
# of Institutions
127Shares Held
67.2MCall Options Held
280KPut Options Held
76.3K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$142 Million2.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$40.4 Million0.55% of portfolio
-
Janus Henderson Group PLC London, X05.57MShares$37.2 Million0.02% of portfolio
-
Goldman Sachs Group Inc New York, NY4.25MShares$28.4 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.17MShares$27.9 Million9.0% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $289M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...